SG/CALL/SARTORIUS STEDIM BIO/255/0.025/21.06.24 Share Price

Warrant

87Q2S

DE000SV9C258

Real-time Euronext Paris 14:33:23 14/05/2024 BST
0.055 EUR +22.22% Intraday chart for SG/CALL/SARTORIUS STEDIM BIO/255/0.025/21.06.24
Current month-18.18%
1 month-91.82%
Date Price Change
14/05/24 0.055 +22.22%
13/05/24 0.045 0.00%
10/05/24 0.045 0.00%
09/05/24 0.045 -18.18%
08/05/24 0.055 0.00%

Real-time Euronext Paris

Last update May 14, 2024 at 02:33 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying SARTORIUS STEDIM BIOTECH
IssuerLogo Issuer Société Générale Société Générale
87Q2S
ISINDE000SV9C258
Date issued 06/07/2023
Strike 255
Maturity 21/06/2024 (38 Days)
Parity 40 : 1
Emission price 0.88
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.71
Lowest since issue 0.035
Delta0.14x
Omega 13.18
Premium22.13x
Gearing95.73x
Moneyness 0.8259
Difference Strike 42.7
Difference Strike %+16.75%
Spread 0.01
Spread %16.67%
Theoretical value 0.0550
Implied Volatility 49.59 %
Total Loss Probability 89.45 %
Intrinsic value 0.000000
Present value 0.0550
Break even 257.20 €
Theta-0.02x
Vega0x
Rho0x

Company Profile

Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany.
Sector
-
More about the company

Ratings for Sartorius Stedim Biotech

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Sartorius Stedim Biotech

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
203.6 EUR
Average target price
251.3 EUR
Spread / Average Target
+23.44%
Consensus
  1. Stock Market
  2. Warrants
  3. 87Q2S Warrant